The Dirty Little Secret about Big Pharma

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, Managerial Accounting.

As the New York Times reports, when Big Pharma companies are under fire for skyrocketing drug prices, they would like you to believe that prices have to be so high to support research and development (R&D). But is that the truth? Questions: 1. What did the authors of the new study find that the 18… Read more »

The Business Model of Overstating Benefits: How Harmful or Ethical?

Posted by & filed under Accounting Principles, Advanced Accounting, Auditing, Financial Accounting, Financial Reporting and Analysis, Financial Statement Analysis, Fraud Accounting, IFRS, Intermediate Accounting, International Accounting, Video Updates.

It is estimated that between 50,000 to 100,000 patients died or had a heart attack as a result of taking the drug Advandia. For seven years, GlaxoSmithKline (GSK) failed to report data that indicated Advandia increases the risk of heart attack by 40%. As we reported back in July, in the biggest health care fraud… Read more »